UPDATE: Jefferies Raises PT on Eli Lilly & Co. as Least-Preferred Name

In a report published Wednesday, Jefferies analyst Jeffrey Holford reiterated an Underperform rating on Eli Lilly & Co. (NYSE: LLY ), and slightly raised the price target from $43.00 to $44.00. In the report, Holford noted, “We remain positive on Pharmaceuticals and see valuation as attractive for most stocks. Our